Gs Investments Inc. cut its stake in shares of McKesson Co. (NYSE:MCK) by 5.0% during the fourth quarter, HoldingsChannel.com reports. The firm owned 9,702 shares of the company’s stock after selling 515 shares during the quarter. Gs Investments Inc.’s holdings in McKesson were worth $1,513,000 at the end of the most recent quarter.
Other institutional investors also recently made changes to their positions in the company. Wealthcare Advisory Partners LLC acquired a new stake in shares of McKesson during the third quarter worth $155,000. Community Financial Services Group LLC acquired a new stake in shares of McKesson during the fourth quarter worth $204,000. Biltmore Wealth Management LLC acquired a new stake in shares of McKesson during the third quarter worth $206,000. Sawyer & Company Inc acquired a new stake in shares of McKesson during the fourth quarter worth $208,000. Finally, RiverGlades Family Offices LLC acquired a new stake in shares of McKesson during the fourth quarter worth $215,000. 85.47% of the stock is currently owned by institutional investors.
A number of equities research analysts have recently issued reports on MCK shares. Needham & Company LLC reaffirmed a “buy” rating and set a $173.00 target price (down from $178.00) on shares of McKesson in a research report on Wednesday, November 1st. ValuEngine lowered McKesson from a “buy” rating to a “hold” rating in a research report on Sunday, December 31st. Evercore ISI assumed coverage on McKesson in a research report on Thursday, January 4th. They set an “outperform” rating and a $179.00 price target on the stock. Credit Suisse Group reissued a “sell” rating and set a $130.00 price target on shares of McKesson in a research report on Friday, February 2nd. Finally, Zacks Investment Research raised McKesson from a “hold” rating to a “buy” rating and set a $177.00 price target on the stock in a research report on Tuesday, December 26th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and eleven have issued a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $177.86.
McKesson Co. (NYSE:MCK) opened at $153.68 on Wednesday. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.07 and a quick ratio of 0.61. McKesson Co. has a 52 week low of $133.82 and a 52 week high of $178.86. The company has a market capitalization of $31,883.55, a PE ratio of 12.32, a price-to-earnings-growth ratio of 1.40 and a beta of 1.23.
McKesson (NYSE:MCK) last issued its earnings results on Thursday, February 1st. The company reported $3.41 EPS for the quarter, beating analysts’ consensus estimates of $2.92 by $0.49. McKesson had a return on equity of 22.98% and a net margin of 2.34%. The firm had revenue of $53.62 billion for the quarter, compared to the consensus estimate of $51.98 billion. During the same quarter in the previous year, the company posted $3.04 earnings per share. The business’s quarterly revenue was up 7.0% compared to the same quarter last year. equities research analysts forecast that McKesson Co. will post 12.71 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Monday, April 2nd. Shareholders of record on Thursday, March 1st will be paid a $0.34 dividend. The ex-dividend date of this dividend is Wednesday, February 28th. This represents a $1.36 dividend on an annualized basis and a yield of 0.88%. McKesson’s dividend payout ratio (DPR) is currently 6.03%.
COPYRIGHT VIOLATION NOTICE: This report was originally published by Ticker Report and is the sole property of of Ticker Report. If you are reading this report on another website, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright legislation. The legal version of this report can be read at https://www.tickerreport.com/banking-finance/3228580/mckesson-co-mck-stake-lessened-by-gs-investments-inc.html.
McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare.
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.